GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Goodbody Health Ltd (AQSE:GDBY) » Definitions » EV-to-Revenue

Goodbody Health (AQSE:GDBY) EV-to-Revenue : -0.17 (As of Jun. 16, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Goodbody Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Goodbody Health's enterprise value is £-2.82 Mil. Goodbody Health's Revenue for the trailing twelve months (TTM) ended in Sep. 2022 was £16.47 Mil. Therefore, Goodbody Health's EV-to-Revenue for today is -0.17.

The historical rank and industry rank for Goodbody Health's EV-to-Revenue or its related term are showing as below:

AQSE:GDBY's EV-to-Revenue is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.24
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-16), Goodbody Health's stock price is £0.0025. Goodbody Health's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 was £0.45. Therefore, Goodbody Health's PS Ratio for today is 0.01.


Goodbody Health EV-to-Revenue Historical Data

The historical data trend for Goodbody Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Goodbody Health EV-to-Revenue Chart

Goodbody Health Annual Data
Trend Jul12 Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Dec21
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.44

Goodbody Health Quarterly Data
Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 0.44 0.27 0.07 0.11

Competitive Comparison of Goodbody Health's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Goodbody Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Goodbody Health's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Goodbody Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Goodbody Health's EV-to-Revenue falls into.



Goodbody Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Goodbody Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-2.819/16.473
=-0.17

Goodbody Health's current Enterprise Value is £-2.82 Mil.
Goodbody Health's Revenue for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was £16.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Goodbody Health  (AQSE:GDBY) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Goodbody Health's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0025/0.452
=0.01

Goodbody Health's share price for today is £0.0025.
Goodbody Health's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was £0.45.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Goodbody Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Goodbody Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Goodbody Health (AQSE:GDBY) Business Description

Traded in Other Exchanges
N/A
Address
Stubbs Lane, Beckington Frome, The Blue Building, Somerset, GBR, BA11 6TE
Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.

Goodbody Health (AQSE:GDBY) Headlines

No Headlines